Deoxyuridine monophosphate reverses resistance to 5FU in 5FU-resistant gastric cancer

被引：0
|
作者：
Mori, R. [1 ]
Tanahashi, T. [1 ]
Okumura, N. [1 ]
Yamaguchi, K. [1 ]
Futamura, M. [1 ]
Yoshida, K. [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Surg Oncol, Gifu, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
209P
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] CHEMOTHERAPY OF HEPATOCELLULAR-CARCINOMA IN FILIPINOS - INTRAVENOUS 5FU ALONE AND 5FU PLUS ADRIAMYCIN
    DOMINGO, EO
    EUFEMIO, GG
    LAO, JY
    AGUSTIN, BM
    PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1981, 19 (02): : 85 - 94
  • [22] Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment
    Anaka, Matthew
    Abdel-Rahman, Omar
    CANCER MANAGEMENT AND RESEARCH, 2021, 14 : 273 - 285
  • [23] RANDOMIZED TRIAL OF COMBINED MODALITY THERAPY (5000 R + 5FU + MECCNU) VS COMBINATION CHEMOTHERAPY (5FU + MECCNU) IN TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
    LIVSTONE, EM
    GASTROENTEROLOGY, 1978, 74 (05) : 1057 - 1057
  • [24] Preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer is a feasible treatment strategy in the elderly
    Dolinsky, C. M.
    Mahmoud, N. N.
    Mick, R.
    Sun, W.
    Whittington, R.
    Solin, L. J.
    Haller, D. G.
    O'Dwyer, P.
    Fry, R. D.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S308 - S308
  • [25] Randomized phase III trial comparing 5FU bolus and low dose leucovorin versus 5FU bolus plus continuous 5FU infusion and high dose LV in metastatic colorectal cancer
    Bosset, JF
    DeGrammont, A
    Milan, C
    Rougier, P
    Bouche, O
    Etienne, PL
    Morvan, F
    Louvet, C
    Guillot, T
    Bedenne, L
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 702 - 702
  • [26] POTENTIATION OF THE ANTI-TUMOR ACTIVITY OF 5FU BY THYMIDINE AND ITS CORRELATION WITH THE FORMATION OF (5FU)RNA
    SPIEGELMAN, S
    NAYAK, R
    SAWYER, R
    STOLFI, R
    MARTIN, D
    CANCER, 1980, 45 (05) : 1129 - 1134
  • [27] Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
    Roberto Petrioli
    Edoardo Francini
    Franco Roviello
    Daniele Marrelli
    Anna Ida Fiaschi
    Letizia Laera
    Giulia Rossi
    V. Bianco
    S. Brozzetti
    Giandomenico Roviello
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 941 - 947
  • [28] GENOTOXIC ACTION OF 5-FLUOROURACIL (5FU)
    ZACCARO, L
    ROSSI, AM
    BATTOLLA, R
    MUTATION RESEARCH, 1987, 181 (02): : 320 - 320
  • [29] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
  • [30] Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience
    Petrioli, Roberto
    Francini, Edoardo
    Roviello, Franco
    Marrelli, Daniele
    Fiaschi, Anna Ida
    Laera, Letizia
    Rossi, Giulia
    Bianco, V.
    Brozzetti, S.
    Roviello, Giandomenico
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (05) : 941 - 947
12345